AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.
Public ClinicalTrials.gov record NCT02511106. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Double-blind, Randomized, Placebo-controlled Multi-centre, Study to Assess the Efficacy and Safety of AZD9291 Versus Placebo, in Patients With Epidermal Growth Factor Receptor Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy (ADAURA).
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To assess the efficacy and safety of AZD9291 versus Placebo, in patients with Epidermal Growth Factor Receptor Mutation Positive stage IB-IIIA non-small cell lung carcinoma, following complete tumour resection with or without adjuvant chemotherapy
Study identification
- NCT ID
- NCT02511106
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 682 participants
Conditions and interventions
Conditions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 21, 2015 (Actual)
- Primary completion
- Apr 11, 2022 (Actual)
- Completion
- Jan 31, 2029 (Estimated)
- Last update posted
- Sep 11, 2026
2015 – 2029
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Los Angeles | California | 90048 | — |
| Research Site | Santa Monica | California | 90404 | — |
| Research Site | Santa Rosa | California | 95403 | — |
| Research Site | Torrance | California | 90505 | — |
| Research Site | Grand Junction | Colorado | 81501 | — |
| Research Site | New Haven | Connecticut | 06520 | — |
| Research Site | Norwalk | Connecticut | 06856 | — |
| Research Site | Fort Myers | Florida | 33901 | — |
| Research Site | Pembroke Pines | Florida | 33028 | — |
| Research Site | St. Petersburg | Florida | 33705 | — |
| Research Site | Athens | Georgia | 30607 | — |
| Research Site | Honolulu | Hawaii | 96819 | — |
| Research Site | Chicago | Illinois | 60612 | — |
| Research Site | Elk Grove Village | Illinois | 60007 | — |
| Research Site | Bethesda | Maryland | 20817 | — |
| Research Site | Brick | New Jersey | 08724 | — |
| Research Site | Florham Park | New Jersey | 07932 | — |
| Research Site | Mineola | New York | 11501 | — |
| Research Site | Pawtucket | Rhode Island | 02860 | — |
| Research Site | Chattanooga | Tennessee | 37404 | — |
| Research Site | Nashville | Tennessee | 37203 | — |
| Research Site | San Antonio | Texas | 78229 | — |
| Research Site | Fort Belvoir | Virginia | 22060 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 215 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02511106, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 11, 2026 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02511106 live on ClinicalTrials.gov.